U.S. regulator on India visit calls for greater drug safety collaboration

[riky]

U.S. regulator on India visit calls for greater drug safety collaboration

By Sumeet Chatterjee and Zeba Siddiqui MUMBAI (Reuters) - The head of the U.S. Food and Drug Administration (FDA) called for more collaboration among regulators to improve drug quality and safety as she wrapped up a visit to India after recent import bans on drugs from a handful of plants in the country. In recent months the FDA has banned the import of drugs and drug ingredients from leading Indian manufacturers including Ranbaxy Laboratories and Wockhardt, citing quality concerns. The bans threaten the image and market share of India's $14 billion pharmaceuticals sector in the United States. ...

Source: You are not allowed to view links. Register or Login